Francesco Deleo

ORCID: 0000-0003-0808-3042
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Epilepsy research and treatment
  • Neuroscience and Neuropharmacology Research
  • Pharmacological Effects and Toxicity Studies
  • Fetal and Pediatric Neurological Disorders
  • Glioma Diagnosis and Treatment
  • Functional Brain Connectivity Studies
  • Neonatal and fetal brain pathology
  • EEG and Brain-Computer Interfaces
  • Autoimmune Neurological Disorders and Treatments
  • Cerebrospinal fluid and hydrocephalus
  • Advanced Neuroimaging Techniques and Applications
  • Neurobiology of Language and Bilingualism
  • Infectious Encephalopathies and Encephalitis
  • Radiomics and Machine Learning in Medical Imaging
  • Olfactory and Sensory Function Studies
  • Ion channel regulation and function
  • Peripheral Neuropathies and Disorders
  • Head and Neck Surgical Oncology
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Computational Drug Discovery Methods
  • Neurological disorders and treatments
  • Long-Term Effects of COVID-19
  • Advanced MRI Techniques and Applications
  • Glycogen Storage Diseases and Myoclonus
  • Advanced Neural Network Applications

Fondazione IRCCS Istituto Neurologico Carlo Besta
2016-2025

Stichting Epilepsie Instellingen Nederland
2024

University of Amsterdam
2024

Amsterdam Neuroscience
2024

University of Florence
2022-2024

Brazilian Institute of Neuroscience and Neurotechnology
2024

Universidade Estadual de Campinas (UNICAMP)
2022-2024

Meyer Children's Hospital
2022-2024

University Medical Center Utrecht
2024

Istituti di Ricovero e Cura a Carattere Scientifico
2023

Herm J. Lamberink Willem M. Otte Ingmar Blümcke Kees P. J. Braun Martin Aichholzer and 95 more Isabel Amorim Javier Aparicio Eleonora Aronica Alexis Arzimanoglou Carmen Barba Jürgen Beck Albert J. Becker Jan Beckervordersandforth Christian G. Bien Ingmar Blümcke István Bódi Kees P. J. Braun Hélène Catenoix Francine Chassoux Mathilde Chipaux Thomas Cloppenborg Roland Coras J. Helen Cross Luca De Palma Jane de Tisi Francesco Deleo Bertrand Devaux Giancarlo Di Gennaro Georg Dorfmüller John S. Duncan Christian E. Elger Katharina Ernst Vincenzo Esposito Martha Feucht Željka Petelin Gadže Rita Garbelli Karin Geleijns António Gil‐Nagel Alexander Grote Thomas Grünwald Renzo Guerrini Hajo M. Hamer Mrinalini Honavar Thomas S. Jacques Antonia Jakovčević Leena Jutila Adam Kalina Reetta Kälviäinen Karl Martin Klein Kristina Koenig Pavel Kršek Manfred Kudernatsch Martin Kudr Herm J. Lamberink Kristina Malmgren Petr Marusič A G Melikyan Katja Menzler Soheyl Noachtar Willem M. Otte Çiğdem Özkara Tom Pieper José Pimentel Savo Raičević Sylvain Rheims Joana Ribeiro Felix Rosenow Karl Rössler Bertil Rydenhag Francisco Sales Victoria San Antonio‐Arce Karl Lothar Schaller Olaf Schijns Theresa O. Scholl Johannes Schramm Andreas Schulze‐Bonhage Raf Sciot Margitta Seeck L V Shishkina Dragoslav Sokić Nicola Specchio Tom Theys Maria Thom Rafael Toledano Joseph Toulouse Mustafa Uzan J. van Loon Wim Van Paesschen Tim J. von Oertzen Floor E. Jansen Frans S.S. Leijten Peter van Rijen Wim G.M. Spliet Angelika Mühlebner Burkhard S. Kasper Susanne Fauser Tilman Polster Thilo Kalbhenn Daniel Delev Andrew W. McEvoy

10.1016/s1474-4422(20)30220-9 article EN The Lancet Neurology 2020-08-18

ABSTRACT Pre‐surgical and post‐surgical data were examined compared from 215 consecutive patients undergoing surgery for intractable epilepsy. Patients selected on the basis of a proven histopathological diagnosis type I focal cortical dysplasia (FCD I), alone or associated with other lesions. The divided into five sub‐groups: i) 66 isolated FCD I, ii) 76 hippocampal sclerosis, iii) 49 tumours, iv) 16 malformations development v) eight anoxic‐ischaemic inflammatory diseases. duration...

10.1684/epd.2010.0327 article EN Epileptic Disorders 2010-09-01

ABSTRACT Focal cortical dysplasias (FCDs) are highly epileptogenic malformations associated with drug‐resistant epilepsy, susceptible to surgical treatment. Among the different types of FCD, type II includes two subgroups based on absence (IIa) or presence (IIb) balloon cells. The aim this retrospective study was investigate possible differences in electroclinical presentations and outcomes between 100 consecutive surgically treated patients FCDs. All underwent a comprehensive presurgical...

10.1684/epd.2012.0525 article EN Epileptic Disorders 2012-09-01

Magnetic resonance imaging-positive temporal lobe atrophy with temporo-polar grey/white matter abnormalities (usually called 'blurring') has been frequently reported in patients epilepsy associated hippocampal sclerosis. The poor distinction of grey and white attributed to various causes, including developmental cortical abnormalities, gliosis, myelin alterations, a non-specific increase water content metabolic/perfusion alterations. However, there is still no consensus regarding the genesis...

10.1093/brain/aws149 article EN Brain 2012-06-22

To test the hypothesis that a multicenter-validated computer deep learning algorithm detects MRI-negative focal cortical dysplasia (FCD).We used clinically acquired 3-dimensional (3D) T1-weighted and 3D fluid-attenuated inversion recovery MRI of 148 patients (median age 23 years [range 2-55 years]; 47% female) with histologically verified FCD at 9 centers to train convolutional neural network (CNN) classifier. Images were initially deemed in 51% patients, whom intracranial EEG determined...

10.1212/wnl.0000000000012698 article EN Neurology 2021-09-14

Patients with presumed nonlesional focal epilepsy-based on either MRI or histopathologic findings-have a lower success rate of epilepsy surgery compared lesional patients. In this study, we aimed to characterize large group patients who underwent despite normal and had no lesion histopathology. Determinants their postoperative seizure outcomes were further studied.

10.1212/wnl.0000000000208007 article EN Neurology 2024-01-30

ABSTRACT The present study included analysis of data from 243 patients surgically treated for Temporal Lobe Epilepsy (TLE). Resection was confined to the temporal lobe, with at least two years follow‐up, and specimens sufficiently preserved allow a precise evaluation both lateral neocortex hippocampus. frequency different types lesion hippocampal sclerosis (HS), isolated or associated neocortical lesions, risk factors surgical outcomes in relation neuropathological findings were evaluated....

10.1684/epd.2009.0279 article EN Epileptic Disorders 2009-12-01

Hippocampal sclerosis (HS) is the most frequent neuropathologic finding in patients undergoing surgery for intractable temporal lobe epilepsy (TLE). The International League Against Epilepsy (ILAE) has recently proposed a new classification of HS based on specific patterns cell loss. aim this study was to investigate relationships between types, their etiologic factors, and short- long-term postsurgical outcomes because drug-resistant TLE with HS.Two hundred thirteen diagnosis minimum...

10.1111/epi.13277 article EN Epilepsia 2015-12-17

In patients with temporal lobe epilepsy (TLE), assessment of language lateralization is important as anterior lobectomy may lead to impairments. Despite the widespread use fMRI, evidence its usefulness in predicting postsurgical performance scant. We investigated whether preoperative functional related performance, peri-ictal aphasia, and can predict outcome one year post-surgery. studied a total 72 TLE (42 left, 30 right), by using three fMRI tasks: Naming, Verb Generation Fluency....

10.1016/j.nicl.2013.07.001 article EN cc-by-nc-nd NeuroImage Clinical 2013-01-01

Abstract Neuronal dendritic arborizations and spines are crucial for a normal synaptic transmission may be critically involved in the pathophysiology of epilepsy. Alterations morphology spine loss mainly hippocampal neurons have been reported both epilepsy animal models human brain tissues from patients with However, it is still unclear whether these abnormalities relate to cause or generated by seizure recurrence. We investigated fine neuronal structures at level organization using Golgi...

10.1093/brain/awaa387 article EN Brain 2020-10-26
Simona Lattanzi Laura Canafoglia Maria Paola Canevini Sara Casciato Valentina Chiesa and 95 more Filippo Dainese Giovanni De Maria Giuseppe Didato Giovanni Falcicchio Martina Fanella Edoardo Ferlazzo Giacomo Fisco Massimo Gangitano Anna Teresa Giallonardo Filippo Sean Giorgi Angela La Neve Oriano Mecarelli Elisa Montalenti Federico Piazza Patrizia Pulitano Pier Paolo Quarato Federica Ranzato Eleonora Rosati Laura Tassi Carlo Di Bonaventura Angela Alicino Michele Ascoli Giovanni Assenza Federica Avorio Valeria Badioni Paola Banfi Emanuele Bartolini Luca Manfredi Basili Vincenzo Belcastro Simone Beretta Irene Berto Martina Biggi Giuseppe Billo Giovanni Boero Paolo Bonanni Jole Bongorno Francesco Brigo Emanuele Caggia Claudia Cagnetti Carmen Calvello Emanuele Cerulli Irelli Carlos E. S. Cesnik Gigliola Chianale Domenico Ciampanelli Roberta Ciuffini Dario Cocito Donato Colella Margerita Contento Cinzia Costa Eduardo Cumbo Alfredo D’Aniello Francesco Deleo Jacopo C. DiFrancesco Giancarlo Di Gennaro Roberta Di Giacomo Alessandra Di Liberto Elisabetta Domina Francesco Donato Fedele Dono Vania Durante Maurizio Elia Anna Estraneo Giacomo Evangelista M. T. Faedda Ylenia Failli Elisa Fallica Jinane Fattouch Alessandra Ferrari Florinda Ferreri Davide Fonti Francesco Fortunato Nicoletta Foschi Teresa Francavilla Rosita Galli Stefano Gazzina Loretta Giuliano Francesco Habetswallner Francesca Izzi Benedetta Kassabian Angelo Labate Concetta Luisi Matteo Magliani Giulia Maira Luisa Mari Daniela Marino Addolorata Mascia Alessandra Mazzeo Stefano Meletti Alessandra Morano Annacarmen Nilo Biagio Orlando Francesco Paladin Maria Grazia Pascarella Chiara Pastori Giada Pauletto

In randomized controlled trials, add-on brivaracetam (BRV) reduced seizure frequency in patients with drug-resistant focal epilepsy. Studies performed a naturalistic setting are useful complement to characterize the drug profile. This multicentre study assessed effectiveness and tolerability of adjunctive BRV large population epilepsy context real-world clinical practice. The BRIVAFIRST (BRIVAracetam First Italian netwoRk STudy) was retrospective, including adult prescribed BRV. Patients...

10.1007/s40263-021-00856-3 article EN cc-by-nc CNS Drugs 2021-09-02

Abstract The identification of the epileptogenic zone (EZ) boundaries is crucial for effective focal epilepsy surgery. We verify value a neurophysiological biomarker ictogenesis, characterized by low‐voltage fast‐activity ictal pattern (chirp) recorded with intracerebral electrodes during invasive presurgical monitoring (stereoelectroencephalography [SEEG]). frequency content SEEG signals was retrospectively analyzed semiautomatic software in 176 consecutive patients epilepsies that either...

10.1111/epi.17995 article EN cc-by-nc-nd Epilepsia 2024-04-30

OBJECTIVE Epilepsy surgery is an effective means of treating focal epilepsy associated with long-term epilepsy-associated tumors. This study evaluated a large population surgically treated patients childhood onset and histologically confirmed diagnosis The authors analyzed seizure outcomes to establish whether the time patients' ages were determinant factors. METHODS separately investigated several presurgical, surgical, postsurgical variables in operated on before (pediatric group) at or...

10.3171/2016.9.jns161176 article EN Journal of neurosurgery 2017-01-13

Objective The contribution of recurring seizures to the progression epileptogenesis is debated. Seizure‐induced brain damage not conclusively demonstrated either in humans or animal models epilepsy. We evaluated expression injury biomarkers on postsurgical tissue obtained from 20 patients with frequent and a long history drug‐resistant focal Methods patterns specific glial, neuronal, inflammatory molecules were by immunohistochemistry core type II cortical dysplasias (FCD‐II), at FCD...

10.1002/ana.25005 article EN Annals of Neurology 2017-07-27

Objective To describe the clinical and paraclinical findings, treatment options long-term outcomes in autoimmune encephalitis (AE), with a close look to epilepsy. Methods In this retrospective observational cohort study, we enrolled patients new-onset seizures context of AE. We compared findings without evidence antibodies. Results Overall, 263 (138 females; median age 55 years, range 4–86) were followed up for time 30 months (range 12–120). Antineuronal antibodies detected 63.50%....

10.1136/jnnp-2022-329195 article EN Journal of Neurology Neurosurgery & Psychiatry 2022-07-25

This retrospective study assessed long-term effectiveness of add-on perampanel (PER) in patients with Lennox-Gastaut syndrome (LGS). Outcomes included time to PER failure and seizure relapse responders. was defined as either discontinuation or initiation another treatment. Seizure responders occurrence a seizure-free increase at least 50% average monthly frequency for those who were Eighty-seven included. Treatment occurred 52 (59.8%) subjects median 12 months. due lack efficacy 27 (52.0%)...

10.1111/epi.17601 article EN cc-by-nc Epilepsia 2023-03-31

Abstract Musicogenic epilepsy (ME) is characterized by seizures triggered music. The epileptogenic focus in this rare reflex often the temporal lobe, although precise localization still unclear. A correlation between ME and presence of GAD65 antibodies indicates a potential immunological pathogenic mechanism. We evaluated 32‐year‐old woman with drug‐resistant lobe as candidate for surgery. In absence clear clinical lateralizing signs, video‐EEG monitoring intracranial electrodes inserted...

10.1002/epi4.13132 article EN cc-by-nc-nd Epilepsia Open 2025-01-21
Simona Lattanzi Laura Canafoglia Maria Paola Canevini Sara Casciato Emanuele Cerulli Irelli and 95 more Valentina Chiesa Filippo Dainese Giovanni De Maria Giuseppe Didato Giancarlo Di Gennaro Giovanni Falcicchio Martina Fanella Edoardo Ferlazzo Massimo Gangitano Angela La Neve Oriano Mecarelli Elisa Montalenti Alessandra Morano Federico Piazza Chiara Pizzanelli Patrizia Pulitano Federica Ranzato Eleonora Rosati Laura Tassi Carlo Di Bonaventura Angela Alicino Michele Ascoli Giovanni Assenza Federica Avorio Valeria Badioni Paola Banfi Emanuele Bartolini Luca Manfredi Basili Vincenzo Belcastro Simone Beretta Irene Berto Martina Biggi Giuseppe Billo Giovanni Boero Paolo Bonanni Jole Bongiorno Francesco Brigo Emanuele Caggia Claudia Cagnetti Carmen Calvello Carlos E. S. Cesnik Gigliola Chianale Domenico Ciampanelli Roberta Ciuffini Dario Cocito Donato Colella Margherita Contento Cinzia Costa Eduardo Cumbo Alfredo D’Aniello Francesco Deleo Jacopo C. DiFrancesco Roberta Di Giacomo Aldo Liberto Elisabetta Domina Fedele Dono Vania Durante Maurizio Elia Anna Estraneo Giacomo Evangelista M. T. Faedda Ylenia Failli Elisa Fallica Jinane Fattouch Alessandra Ferrari Florinda Ferreri Giacomo Fisco Davide Fonti Francesco Fortunato Nicoletta Foschi Teresa Francavilla Rosita Galli Stefano Gazzina Anna Teresa Giallonardo Filippo Sean Giorgi Loretta Giuliano Francesco Habetswallner Francesca Izzi Benedetta Kassabian Angelo Labate Concetta Luisi Matteo Magliani Giulia Maira Luisa Mari Daniela Marino Addolorata Mascia Alessandra Mazzeo Stefano Meletti Chiara Milano Annacarmen Nilo Biagio Orlando Francesco Paladin Maria Grazia Pascarella Chiara Pastori Giada Pauletto

Subjects with intellectual disability are usually excluded from clinical trials and there is limited evidence-based guidance for the choice of antiseizure medications in this vulnerable population. The study explored effectiveness brivaracetam (BRV) people epilepsy disability. BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) was a 12-month retrospective, multicenter including adults prescribed adjunctive BRV. Main outcomes included rates seizure‐freedom, seizure response (≥ 50%...

10.1007/s40120-025-00717-x article EN cc-by-nc Neurology and Therapy 2025-03-12
Coming Soon ...